These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Erythema multiforme after use of topical dorzolamide.
    Author: Munshi V, Ahluwalia H.
    Journal: J Ocul Pharmacol Ther; 2008 Feb; 24(1):91-3. PubMed ID: 18370879.
    Abstract:
    Erythema multiforme may be a mild condition (erythema multiforme minor), or it may be a severe, possibly life-threatening condition (erythema multiforme major or Stevens-Johnson syndrome). Dorzolamide is a carbonic anhydrase inhibitor, which reduces intraocular pressure by suppressing aqueous production. In this paper we report on a patient who developed erythema multiforme following the use of topical dorzolamide.
    [Abstract] [Full Text] [Related] [New Search]